StockWatch
·
HomeLiveReports

SANDU PHARMACEUTICALS LTD. Q4 FY25 Results

SANDUPHQQ4 FY25 Results
Filing
MetricValue (₹ Cr)
Revenue14.07
Total Income14.14
Expenditure13.80
PBT0.34
Net Profit0.33
OPM3.18%
NPM2.31%
EPS0.34
View full financials

Informational and educational content only. Not investment advice.